VRDN - Viridian Therapeutics Inc
IEX Last Trade
14.66
-0.340 -2.319%
Share volume: 919,460
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$15.00
-0.34
-2.27%
Summary score
24%
Profitability
25%
Dept financing
3%
Liquidity
75%
Performance
16%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-20.12%
Return on assets
-17.48%
Return on sales
-44797.9%
Return on invested capital
239.25%
Total debt ratio
13.69%
Debt ratio change over timeo
-0.92%
Current Ratio
12.32%
Quick Ratio
12.32%
Cash Position Ratio
12.01%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-14.42%
Return on assets
-13.97%
Return on sales
-82595.14%
Return on invested capital
250.98%
Total debt ratio
10.33%
Debt ratio change over timeo
-0.95%
Current Ratio
17.07%
Quick Ratio
17.07%
Cash Position Ratio
16.63%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-8.33%
Return on assets
-8.87%
Return on sales
-77634.72%
Return on invested capital
215.13%
Total debt ratio
7.59%
Debt ratio change over time
-0.97%
Current Ratio
23.99%
Quick Ratio
23.99%
Cash Position Ratio
23.47%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-112.93%
Return on assets
-111.06%
Return on sales
-24394.21%
Return on invested capital
44.14%
Total debt ratio
-91.63%
Debt ratio change over time
-0.92%
Current Ratio
5.44%
Quick Ratio
5.44%
Cash Position Ratio
5.28%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | VRDN | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -20.12% | 13.79% | 34.47% | 7.43% |
| Return on assets | -17.48% | 2.76% | 3.15% | 5.62% |
| Return on sales | -44797.9% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 239.25% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 40% | 60% | 57% |
| Total debt ratio | 13.69% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.92% | 308.97% | -6.99% | 1.18% |
| Dept financing | 4% | 50% | 25% | 7% |
| Current Ratio | 17.07% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 17.07% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 16.63% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 4% | 9% | 21% |
| Short-term ratios | VRDN | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -14.42% | 13.77% | 13.25% | 3.8% |
| Return on assets | -13.97% | 2.43% | 1.89% | 3.09% |
| Return on sales | -82595.14% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 250.98% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 65% | 59% | 58% |
| Total debt ratio | 10.33% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.95% | 46.38% | -72.08% | 1.51% |
| Dept financing | 3% | 50% | 25% | 7% |
| Current Ratio | 17.07% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 17.07% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 16.63% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 3% | 8% | 19% |